Ziprasidone alternative for olanzapine-induced hyperglycemia [1]

American Journal of Psychiatry

Volumn 159, Issue 9, 2002, Pages 1606-

  Spivak, Baruch ^a   Alamy, Sayed S ^a   Jarskog, L Fredrik ^a   Sheitman, Brian B ^a   Lieberman, Jeffrey A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; ISOTHIAZOLE DERIVATIVE; METFORMIN; OLANZAPINE; PIPERAZINE DERIVATIVE; ZIPRASIDONE;

ADULT; CASE REPORT; DIET RESTRICTION; DRUG EFFICACY; HUMAN; HYPERGLYCEMIA; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SOMNOLENCE; TREATMENT OUTCOME; VERTIGO;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; MALE; PIPERAZINES; PIRENZEPINE; SCHIZOPHRENIA, PARANOID; THIAZOLES; TREATMENT OUTCOME;

EID: 0036712893     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.9.1606     Document Type: Letter

References (3)

1. New onset diabetes and atypical antipsychotics
2. Introduction: Ziprasidone appears to offer important therapeutic and tolerability advantages over conventional, and some novel, antipsychotics
3. Olanzapine-induced glucose dysregulation